Shell Asset Management Co. Has $272,000 Stock Holdings in DaVita Inc. (NYSE:DVA)

Shell Asset Management Co. decreased its holdings in shares of DaVita Inc. (NYSE:DVA) by 36.9% in the 4th quarter, HoldingsChannel reports. The firm owned 1,817 shares of the company’s stock after selling 1,062 shares during the period. Shell Asset Management Co.’s holdings in DaVita were worth $272,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. SBI Securities Co. Ltd. acquired a new stake in DaVita during the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC lifted its holdings in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after purchasing an additional 100 shares during the last quarter. Canada Post Corp Registered Pension Plan acquired a new stake in DaVita during the 4th quarter valued at $55,000. Venturi Wealth Management LLC lifted its holdings in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after purchasing an additional 152 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Stock Up 1.1%

Shares of NYSE DVA opened at $145.23 on Monday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a 52 week low of $131.44 and a 52 week high of $179.60. The stock has a market capitalization of $11.16 billion, a P/E ratio of 13.52, a PEG ratio of 1.07 and a beta of 1.14. The stock’s fifty day moving average is $145.68 and its 200 day moving average is $153.57.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.25. DaVita had a return on equity of 115.48% and a net margin of 7.31%. The company had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter last year, the business earned $2.26 earnings per share. DaVita’s revenue was up 5.0% on a year-over-year basis. Sell-side analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DVA has been the topic of several recent research reports. Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research report on Friday, February 21st. StockNews.com upgraded DaVita from a “hold” rating to a “buy” rating in a research report on Friday, April 25th. Finally, Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, DaVita has an average rating of “Hold” and a consensus price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.